Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Accounts Payables (2020 - 2025)

Historic Accounts Payables for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $4.6 million.

  • NeuroPace's Accounts Payables rose 11250.0% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 11250.0%. This contributed to the annual value of $3.0 million for FY2024, which is 2667.24% up from last year.
  • Per NeuroPace's latest filing, its Accounts Payables stood at $4.6 million for Q3 2025, which was up 11250.0% from $4.7 million recorded in Q2 2025.
  • NeuroPace's 5-year Accounts Payables high stood at $4.7 million for Q2 2025, and its period low was $968000.0 during Q2 2021.
  • For the 5-year period, NeuroPace's Accounts Payables averaged around $2.3 million, with its median value being $2.1 million (2022).
  • Per our database at Business Quant, NeuroPace's Accounts Payables plummeted by 1790.84% in 2023 and then skyrocketed by 11250.0% in 2025.
  • NeuroPace's Accounts Payables (Quarter) stood at $1.4 million in 2021, then soared by 55.81% to $2.1 million in 2022, then grew by 8.62% to $2.3 million in 2023, then rose by 26.67% to $3.0 million in 2024, then skyrocketed by 55.38% to $4.6 million in 2025.
  • Its Accounts Payables stands at $4.6 million for Q3 2025, versus $4.7 million for Q2 2025 and $4.0 million for Q1 2025.